T. Rowe Price Associates’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-633,418
| Closed | -$1.16M | – | 2967 |
|
|
2022
Q2 | $1.16M | Sell |
633,418
-27,645
| -4% | -$50.6K | ﹤0.01% | 1822 |
|
|
2022
Q1 | $1.77M | Buy |
661,063
+1,200
| +0.2% | +$3.2K | ﹤0.01% | 1730 |
|
|
2021
Q4 | $2.86M | Sell |
659,863
-2,802
| -0.4% | -$12.1K | ﹤0.01% | 1600 |
|
|
2021
Q3 | $3.37M | Sell |
662,665
-25,659
| -4% | -$131K | ﹤0.01% | 1575 |
|
|
2021
Q2 | $4.36M | Sell |
688,324
-1,007,942
| -59% | -$6.38M | ﹤0.01% | 1527 |
|
|
2021
Q1 | $13.1M | Buy |
1,696,266
+1,009,792
| +147% | +$7.81M | ﹤0.01% | 1349 |
|
|
2020
Q4 | $4.5M | Sell |
686,474
-200
| -0% | -$1.31K | ﹤0.01% | 1455 |
|
|
2020
Q3 | $4.57M | Hold |
686,674
| – | – | ﹤0.01% | 1413 |
|
|
2020
Q2 | $5.72M | Buy |
686,674
+276
| +0% | +$2.3K | ﹤0.01% | 1370 |
|
|
2020
Q1 | $5.27M | Buy |
686,398
+210
| +0% | +$1.61K | ﹤0.01% | 1332 |
|
|
2019
Q4 | $5.7M | Sell |
686,188
-1,518,913
| -69% | -$12.6M | ﹤0.01% | 1378 |
|
|
2019
Q3 | $16.3M | Sell |
2,205,101
-595,771
| -21% | -$4.4M | ﹤0.01% | 1207 |
|
|
2019
Q2 | $31.4M | Sell |
2,800,872
-289,801
| -9% | -$3.25M | ﹤0.01% | 1029 |
|
|
2019
Q1 | $33.2M | Sell |
3,090,673
-1,000,853
| -24% | -$10.8M | ﹤0.01% | 1016 |
|
|
2018
Q4 | $61.8M | Buy |
4,091,526
+3,923
| +0.1% | +$59.2K | 0.01% | 744 |
|
|
2018
Q3 | $75.6M | Buy |
4,087,603
+838,139
| +26% | +$15.5M | 0.01% | 765 |
|
|
2018
Q2 | $74.3M | Buy |
3,249,464
+377,032
| +13% | +$8.62M | 0.01% | 751 |
|
|
2018
Q1 | $81.7M | Buy |
2,872,432
+2,442,345
| +568% | +$69.5M | 0.01% | 698 |
|
|
2017
Q4 | $9.08M | Buy |
430,087
+120,004
| +39% | +$2.53M | ﹤0.01% | 1342 |
|
|
2017
Q3 | $5.63M | Buy |
310,083
+67,393
| +28% | +$1.22M | ﹤0.01% | 1406 |
|
|
2017
Q2 | $3.76M | Buy |
242,690
+94,385
| +64% | +$1.46M | ﹤0.01% | 1449 |
|
|
2017
Q1 | $2.56M | Sell |
148,305
-52,898
| -26% | -$913K | ﹤0.01% | 1522 |
|
|
2016
Q4 | $2.21M | Buy |
+201,203
| New | +$2.21M | ﹤0.01% | 1533 |
|
|
2016
Q3 | – | Sell |
-15,000
| Closed | -$153K | – | 2534 |
|
|
2016
Q2 | $153K | Buy |
+15,000
| New | +$153K | ﹤0.01% | 2371 |
|